UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

10-Q

(Mark One)

x QUARTERLY

REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For

the quarterly period ended July 1, 2006

or

o TRANSITION REPORT PURSUANT TO

SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the transition period

from

to .

Commission

File Number: 000-10030

APPLE COMPUTER, INC.

(Exact name of registrant

as specified in its charter)

CALIFORNIA

942404110

(State

or other jurisdiction

(I.R.S.

Employer Identification No.)

of

incorporation or organization)

1 Infinite Loop

Cupertino, California

95014

(Address

of principal executive offices)

(Zip

Code)

Registrant s telephone

number, including area code: (408) 996-1010

Indicate

by check mark whether the registrant (1) has filed all reports required to be

filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the

preceding 12 months (or for such shorter period that the registrant was

required to file such reports), and (2) has been subject to such filing

requirements for the past 90 days.

Yes x No o

Indicate by check mark whether the

registrant is a large accelerated filer, an accelerated filer, or a

non-accelerated filer. See definition of

accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange

Act.

Large

accelerated filer x

Accelerated

filer o

Non-accelerated

filer o

Indicate by check mark whether the

registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes o No x

859,273,757 shares of

common stock issued and outstanding as of December 13, 2006

Explanatory

Note

In this Form 10-Q,

Apple Computer, Inc. ( Apple or the Company ) is restating its condensed

consolidated balance sheet as of September 24, 2005, the related consolidated

statements of operations for the three and nine months ended June 25, 2005, and

the related consolidated statement of cash flows for the nine months ended June

25, 2005. In the Company s Form 10-K for

the year ended September 30, 2006 to be filed with the Securities and Exchange

Commission (the 2006 Form 10-K ), the Company is restating its consolidated

balance sheet as of September 24, 2005, and the related consolidated statements

of operations, shareholders equity, and cash flows for each of the fiscal

years ended September 24, 2005 and September 25, 2004, and each of the quarters

in fiscal year 2005.

The Company s 2006

Form 10-K also reflects the restatement of Selected Consolidated Financial

Data in Item 6 for the fiscal years ended September 2005, 2004, 2003, and

2002, and Management s Discussion and Analysis of Financial Condition and

Results of Operations in Item 7 for the fiscal years ended September 24, 2005

and September 25, 2004.

Previously filed

annual reports on Form 10-K and quarterly reports on Form 10-Q affected by the

restatements have not been amended and should not be relied on.

On

June 29, 2006, the Company announced that an internal review had discovered

irregularities related to the issuance of certain stock option grants made

between 1997 and 2001, including a grant to its Chief Executive Officer ( CEO )

Steve Jobs. The Company also announced

that a Special Committee of outside directors ( Special Committee ) had been

formed and had hired independent counsel to conduct a full investigation of the

Company s past stock option granting practices. On October 4, 2006, the

Company announced the key results of the Special Committee s investigation,

which are set forth in the Company s Form 8-K filed on that date.

As

a result of the internal review and the independent investigation, management

has concluded, and the Audit and Finance Committee of the Board of Directors

agrees, that incorrect measurement dates were used for financial accounting

purposes for certain stock option grants made in prior periods. Therefore, the Company has recorded

additional non-cash stock-based compensation expense and related tax effects

with regard to past stock option grants, and the Company is restating previously

filed financial statements in this Form 10-Q and the 2006 Form 10-K. These adjustments, after tax, amounted to $4

million, $7 million, and $10 million in fiscal years 2006, 2005 and 2004,

respectively. The adjustment to 2006 was

recorded in the fourth quarter of fiscal year 2006 due to its insignificance.

The

independent counsel and its forensic accountants ( Investigative Team )

reviewed the facts and circumstances surrounding stock option grants made on

259 dates. The Investigative Team spent over 26,500 person-hours searching more

than one million physical and electronic documents and interviewing more than

40 current and former directors, officers, employees, and advisors. Based on a review of the totality of evidence

and the applicable law, the Special Committee found no misconduct by current

management. The Special Committee s investigation identified a number of grants

for which grant dates were intentionally selected in order to obtain favorable

exercise prices. The terms of these and

certain other grants, as discussed below, were finalized after the originally

assigned grant dates. The Special

Committee concluded that the procedures for granting, accounting for, and

reporting stock option grants did not include sufficient safeguards to prevent

manipulation. Although the investigation found that CEO Steve Jobs was aware or

recommended the selection of some favorable grant dates, he did not receive or

financially benefit from these grants or appreciate the accounting

implications. The Special Committee also found that the investigation had

raised serious concerns regarding the actions of two former officers in

connection with the accounting, recording and reporting of stock option grants.

Based

on the evidence and findings from the Company s internal review and the Special

Committee s independent investigation, an analysis was performed of the measurement

dates for the 42,077 stock option grants made on 259 dates between October 1996

and January 2003 (the relevant period ). The Company believes that the

analysis was properly limited to the relevant period. In addition to analyzing

all grants made during the relevant period, the Company sampled certain grants

between 1994 and 1997 and found none that required accounting adjustments. The

first grants for which stock-based compensation expense is required are dated

December 29, 1997. The Company also examined grants made after the relevant

period and found none that required accounting adjustments.

Moreover,

in the years after 2002, Apple made significant changes in its stock option

granting practices in response to evolving legal, regulatory and accounting

requirements.

Consistent

with the accounting literature and recent guidance from the Securities and

Exchange Commission ( SEC ), the grants during the relevant period were

organized into categories based on grant type and process by which the grant

was finalized. The Company analyzed the evidence related to each category of

grants including, but not limited to, electronic and physical documents,

document metadata, and witness interviews.

Based on the relevant facts and circumstances, the Company applied the

controlling accounting standards to determine, for every grant within each

category, the proper measurement date.

If the measurement date is not the originally assigned grant date,

accounting adjustments were made as required, resulting in stock-based

compensation expense and related tax effects.

The 42,077 grants were classified as follows: (1) 17 grants to persons

elected or appointed to the Board of Directors ( director grants ); (2) 3,892 grants

to employees under the Monday/Tuesday Plan described below ( Monday/Tuesday

grants ); (3) 27,096 grants made in broad-based awards to large numbers of

employees, usually on an annual basis ( focal grants ); (4) 9,988 other grants

ratified at meetings of the Board or Compensation Committee ( meeting grants );

(5) 1,082 other grants ratified by unanimous written consent ( UWC ) of the

Board or Compensation Committee ( other UWC grants ); and (6) two grants to the

CEO ( CEO grants ). All references to

the number of option shares, option exercise prices and share prices in this

Explanatory Note have not been adjusted for any subsequent stock splits.

With the exception of director grants, all stock option grants were

subject to ratification by the Board or Compensation Committee at a meeting or

by UWC. Following approval of the grants

at a meeting or by UWC, the Company s legal staff would prepare a Secretary s

Certificate certifying the ratification of the grants. Based on the facts and circumstances

described below, the Company has concluded that the recipients and terms of

certain grants were fixed for accounting purposes before ratification pursuant

to parameters previously approved by the Board or Compensation Committee

through the Monday/Tuesday Plan and the focal process. As further discussed below, within these

parameters, management had the authority to determine the recipients and terms

for each grant. Thus, the Company has

concluded that the measurement dates for these grants occurred when

management s process for allocating these grants was completed and the grants

were ready for ratification, which was considered perfunctory. With regard to all other grants, the Company

has concluded that the grants were finalized and the measurement dates occurred

when the grants were ratified. For many

grants, however, the dates of ratification cannot be established because the

dates the UWCs were executed by the Board or Compensation Committee members or

received by the Company are not available.

For such grants, the Company has concluded that the date of the

preparation of the Secretary s Certificate is the best alternative for

determining the actual date of ratification.

As discussed below, the Company s analysis determined that the originally

assigned grant dates for 6,428 grants on 42 dates are not the proper

measurement dates. Accordingly, after

accounting for forfeitures, the Company has recognized stock-based compensation

expense of $105 million on a pre-tax basis over the respective awards vesting

terms. No adjustments were required for the remaining 35,649 grants. The adjustments were determined by category

as follows:

Director Grants Seventeen director grants were made during the

relevant period. Two director grants

were made pursuant to a 1997 plan that dated the grants on the enactment of the

plan. The remaining fifteen grants were

automatically made under the Director Stock Option Plan for non-employee

directors, which was approved by shareholders in 1998, on the date of a

director s election or appointment to the Board and on subsequent

anniversaries, beginning on the fourth anniversary. Accordingly, the analysis determined that the

originally assigned grant date for each director grant is the measurement date,

and no accounting adjustments are required.

Monday/Tuesday Grants Beginning in December 1998, 3,892 new hire

grants and grants for promotion and retention purposes ( promotion/retention

grants ) were made during the relevant period under the Monday/Tuesday

Plan. Under the Monday/Tuesday Plan,

new hire grants made within pre-established guidelines approved by the Board or

Compensation Committee were dated on the Monday that the recipient started work

(or the following Monday, if the recipient started on another day). The

Company s analysis showed this process to be reliable with very low error

rates. Promotion/retention grants, also

based on pre-established guidelines, were made generally on the first Tuesday

of each month. The Company has concluded that the new hire and

promotion/retention grants made

pursuant to the Monday/Tuesday Plan within pre-established guidelines

do not require adjustment, with the exception of six grants that were

erroneously dated before the employees start dates. For 120 new hire and

promotion/retention grants made outside the guidelines, however, the Company

has concluded that the measurement dates are the dates of ratification by the

Board or Compensation Committee rather than the dates used for grants within

guidelines. Accordingly, based on the

methodology described above, the Company has recognized stock-based

compensation expense of $6 million from 126 grants. If other dates in the period between the

preparation of the UWC and the preparation of the Secretary s Certificate had

been used as measurement dates for grants whose actual ratification dates are

unknown, the total stock-based compensation expense would have ranged from

approximately $3 million to $7 million.

Focal Grants During the relevant period, 27,096 focal grants were

made to employees typically on an annual basis as part of an extensive process

that required several months to complete. Pursuant to limits, guidelines and

practices previously approved by the Board or Compensation Committee, managers

throughout the Company would make recommendations for grants to employees in

their areas of responsibility. After

senior management had determined that the grants were made in accordance with

these established limits, guidelines and practices, management treated the

grants as final when they were submitted to the Board or Compensation Committee

for ratification. The Company has

concluded that for 5,595 grants on five dates, the originally assigned grant

dates are not the proper measurement dates.

For these grants, management s process for finalizing the grants was

completed after the originally assigned grant dates. As a result, the Company has recognized $29

million of stock-based compensation expense.

For two of the five grant dates comprising 3,744 grants, the evidence

shows that the grants were finalized and the measurement date occurred one day

after the originally assigned grant dates.

The grants on these two dates represent more than $16 million of the

total $29 million of stock-based compensation expense resulting from focal

grants.

Other Meeting Grants During the relevant period, meetings of the

Board or Compensation Committee were held to ratify 9,988 grants that are not

Monday/Tuesday, focal or CEO grants. The grant dates and measurement dates for

these grants are the meeting dates when the grants were ratified, with the

exception of 46 grants. Forty-two of

these 46 grants are dated concurrent with a meeting that considered and

approved certain grants, but the evidence indicates that all of the grants may

not have been finalized until a later date. One of the 46 grants was approved and dated at

another meeting, but the recipient, who was becoming employed by the Company as

part of a corporate acquisition, did not start until a later date. Two other

grants were approved before the employees start dates. Another grant was mistakenly cancelled and

subsequently reinstated, requiring an accounting adjustment. Thus, for these 46

grants the Company has concluded that the originally assigned grant dates are

not the proper measurement dates. As a

result, the Company has recognized $2 million of stock-based compensation

expense.

Other UWC Grants During the relevant period, 1,082 grants were

approved by UWCs for a variety of purposes, including executive recruitment,

retention, promotion and new hires outside the Monday/Tuesday process. These

grants were not made pursuant to pre-established guidelines adopted by the

Board or Compensation Committee. Therefore, the Company has concluded that

these grants were not finalized for accounting purposes until ratification by

the Board or Compensation Committee. Accordingly, for 660 grants, the Company

has concluded that the originally assigned grant dates are not the proper

measurement dates. As a result, the Company has recognized $48 million of

stock-based compensation expense. If other dates in the period from the

preparation of the UWC to the preparation of the Secretary s Certificate had

been used as measurement dates for grants whose actual ratification dates are

unknown, the total stock-based compensation would have ranged from

approximately $35 million to $56 million.

CEO Grants During the relevant period, the Company made two grants to

CEO Steve Jobs. The first grant, dated

January 12, 2000, was for 10 million option shares. The second grant, dated October 19, 2001, was

for 7.5 million option shares. Both grants were cancelled in March 2003 prior

to being exercised, when Mr. Jobs received 5 million shares of restricted

stock.

With respect to the grant dated January 12, 2000, the Board on December

2, 1999, authorized a special CEO Compensation Committee to grant Mr. Jobs up

to 15 million shares. The evidence

indicates that the CEO Compensation Committee finalized the terms of the grant

on January 12, 2000, although the Committee s action was memorialized in a UWC transmitted

on January 18, 2000. Because the measurement date is the originally assigned

grant date, the Company has not recognized any stock-based compensation expense

from this grant. If the Company had determined

that the measurement date was the date when the UWC was executed or

received, then additional stock-based compensation would have been recognized.

The grant dated October 19, 2001 was originally approved at a Board

meeting on August 29, 2001, with an exercise price of $17.83. The terms of the grant, however, were not

finalized until December 18, 2001. The

grant was dated October 19, 2001, with an exercise price of $18.30. The approval for the grant was improperly

recorded as occurring at a special Board meeting on October 19, 2001. Such a special Board meeting did not

occur. There was no evidence, however,

that any current member of management was aware of this irregularity. The Company has recognized $20 million in

stock-based compensation expense for this grant, reflecting the difference

between the exercise price of $18.30 and the share price on December 18, 2001

of $21.01.

The incremental impact from recognizing stock-based compensation

expense resulting from the investigation of past stock option grants is as

follows (dollars in millions):

Fiscal Year

Pre-Tax Expense (Income)

After Tax Expense

1998

(1

1999

2000

13

2001

19

13

2002

29

23

2003

16

12

2004

13

10

2005

2006

Total

105

84

Additionally, the Company has restated the pro forma

expense under Statement of Financial Accounting Standards ( SFAS ) No. 123 in

Note 1 of the Notes to Condensed Consolidated Financial Statements of this Form

10-Q and in Note 1 of the Notes to Consolidated Financial Statements of the

2006 Form 10-K to reflect the impact of these adjustments.

PART I.

FINANCIAL INFORMATION

Item 1.

Financial Statements

APPLE COMPUTER, INC.

CONDENSED

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in millions, except share and per share amounts)

Three Months Ended

Nine Months Ended

July 1,

2006

June 25,

2005

July 1,

2006

June 25,

2005

As Restated (1)

As Restated (1)

Net sales

4,370

3,520

14,478

10,253

Cost of sales

(2)

3,045

2,476

10,292

7,246

Gross margin

1,325

1,044

4,186

3,007

Operating

expenses:

Research and development (2)

175

145

533

388

Selling, general, and administrative (2)

584

473

1,808

1,393

Total operating expenses

759

618

2,341

1,781

Operating income

566

426

1,845

1,226

Other income and

expense

95

46

252

105

Income before

provision for income taxes

661

472

2,097

1,331

Provision for

income taxes

189

153

650

431

Net income

472

319

1,447

900

Earnings per

common share:

Basic

0.55

0.39

1.72

1.12

Diluted

0.54

0.37

1.65

1.05

Shares used in

computing earnings per share (in thousands):

Basic

851,375

815,092

840,759

804,098

Diluted

876,368

860,803

876,971

853,238

(1) See Note 2,

Restatement of Condensed Consolidated Financial Statements, in Notes to

Condensed Consolidated Financial Statements.

(2) Includes stock-based

compensation expense, which was allocated as follows:

Cost of sales

16

Research and development

12

40

Selling,

general, and administrative

19

10

67

30

See accompanying Notes to Condensed Consolidated

Financial Statements.

APPLE COMPUTER, INC.

CONDENSED

CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except share amounts)

July 1, 2006

September 24, 2005

As Restated (1)

ASSETS:

Current assets:

Cash and cash equivalents

8,013

3,491

Short-term investments

1,163

4,770

Accounts receivable, less allowances of $51 and $46,

respectively

1,089

895

Inventories

213

165

Deferred tax assets

491

331

Other current assets

1,522

648

Total current assets

12,491

10,300

Property, plant,

and equipment, net

1,197

817

Goodwill

38

69

Acquired

intangible assets, net

37

27

Other assets

1,351

303

Total assets

15,114

11,516

LIABILITIES AND SHAREHOLDERS EQUITY:

Current

liabilities:

Accounts payable

2,513

1,779

Accrued expenses

2,510

1,708

Total current liabilities

5,023

3,487

Non-current

liabilities

761

601

Total liabilities

5,784

4,088

Commitments and

contingencies

Shareholders

equity:

Common stock, no par value; 1,800,000,000 shares

authorized;

852,987,629 and 835,019,364 shares issued and outstanding, respectively

4,249

3,564

Deferred stock compensation

(61

Retained earnings

5,065

3,925

Accumulated other comprehensive income

16

Total shareholders equity

9,330

7,428

Total

liabilities and shareholders equity

15,114

11,516

(1) See Note 2,

Restatement of Condensed Consolidated Financial Statements, in Notes to

Condensed Consolidated Financial Statements.

See accompanying Notes to

Condensed Consolidated Financial Statements.

APPLE COMPUTER, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

Nine Months Ended

July 1, 2006

June 25, 2005

As Restated (1)

Cash and cash

equivalents, beginning of the period

3,491

2,969

Operating

Activities:

Net income

1,447

900

Adjustments to reconcile net income to cash

generated by operating activities:

Depreciation, amortization, and accretion

159

128

Stock-based compensation expense

123

37

Provision for deferred income taxes

201

Excess tax benefits from stock options

279

Gain on sale of PowerSchool net assets

(4

Loss on disposition of property, plant, and

equipment

Changes in

operating assets and liabilities:

Accounts receivable

(194

(53

Inventories

(48

(92

Other current assets

(880

(11

Other assets

(1,113

(17

Accounts payable

734

79

Other liabilities

735

527

Cash generated by operating activities

1,165

1,783

Investing

Activities:

Purchases of short-term investments

(4,393

(7,624

Proceeds from maturities of short-term

investments

7,827

5,108

Proceeds from sales of short-term investments

175

582

Purchases of long-term investments

(12

Proceeds from sale of PowerSchool net assets

40

Purchases of property, plant, and equipment

(512

(164

Other

(39

(29

Cash generated by (used for) investing activities

3,086

(2,127

Financing

Activities:

Proceeds from issuance of common stock

286

469

Excess tax benefits from stock-based compensation

339

Repurchases of common stock

(354

Cash generated by financing activities

271

469

Increase in cash

and cash equivalents

4,522

125

Cash and cash

equivalents, end of the period

8,013

3,094

Supplemental

cash flow disclosure:

Cash paid for income taxes, net

108

108

(1) See Note 2,

Restatement of Condensed Consolidated Financial Statements, in Notes to

Condensed Consolidated Financial Statements.

See accompanying Notes to Condensed Consolidated

Financial Statements.

APPLE COMPUTER, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 1 - Summary of Significant

Accounting Policies

Apple Computer, Inc. and

its wholly-owned subsidiaries ( Apple or the Company ) designs, manufactures,

and markets personal computers and related software, services, peripherals, and

networking solutions. The Company also

designs, develops, and markets a line of portable digital music players along

with related accessories and services including the online sale of third-party

audio and video products. The Company

sells its products worldwide through its online stores, its retail stores, its

direct sales force, and third-party wholesalers, resellers, and value-added

resellers. In addition, the Company

sells a variety of third-party Macintosh and iPod compatible products including

application software, printers, storage devices, speakers, headphones, and

various other accessories and supplies through its online and retail

stores. The Company sells to education,

consumer, creative professional, business, and government customers.

Basis of

Presentation and Preparation

The accompanying

condensed consolidated financial statements include the accounts of the

Company. Intercompany accounts and

transactions have been eliminated. The preparation of these condensed

consolidated financial statements in conformity with U.S. generally accepted

accounting principles requires management to make estimates and assumptions

that affect the amounts reported in these condensed consolidated financial

statements and accompanying notes. Actual results could differ materially from

those estimates. Certain prior year amounts in the consolidated financial

statements and notes thereto have been reclassified to conform to the current

year presentation.

These condensed

consolidated financial statements and accompanying notes should be read in

conjunction with the Company s annual consolidated financial statements and the

notes thereto for the fiscal year ended September 30, 2006, included in the

2006 Annual Report on Form 10-K to be filed with the Securities and Exchange

Commission (the 2006 Form 10-K ).

Typically, the Company s

fiscal year ends on the last Saturday of September. Fiscal year 2005 was a

52-week year. However, approximately every six years, the Company reports a

53-week fiscal year to align its fiscal quarters with calendar quarters by

adding a week to its first fiscal quarter. The Company added this additional

week in the first fiscal quarter of its fiscal year 2006. Unless otherwise stated, references to

particular years or quarters refer to the Company s fiscal years ended in

September and the associated quarters of those fiscal years.

Software Development Costs

Research and

development costs are generally expensed as incurred. Development costs of computer software to be

sold, leased, or otherwise marketed are subject to capitalization beginning

when a product s technological feasibility has been established and ending when

a product is available for general release to customers pursuant to Statement

of Financial Accounting Standards ( SFAS ) No. 86, Computer

Software to be Sold, Leased, or Otherwise Marketed. In most

instances, the Company s products are released soon after technological

feasibility has been established. Therefore, costs incurred subsequent to

achievement of technological feasibility are usually not significant, and

generally all software development costs have been expensed as incurred.

In 2004, the Company

began incurring substantial development costs associated with Mac OS X version

10.4 Tiger ( Tiger ) subsequent to achievement of technological feasibility as

evidenced by public demonstration in August 2004 and the subsequent release of

a developer beta version of the product. During the first nine months of 2005, the

Company capitalized $29.7 million of costs associated with the development of

Tiger. In accordance with SFAS No. 86,

amortization of this asset to cost of sales began in April 2005 when the

Company started shipping Tiger and is being recognized on a straight-line basis

over a three-year estimated useful life.

Stock-Based Compensation

On September 25,

2005, the Company adopted SFAS No. 123 (revised 2004) ( SFAS No. 123R ), Share-Based Payment, which addresses the accounting for

stock-based payment transactions in which an enterprise receives employee

services in exchange for (a) equity instruments of the enterprise or (b)

liabilities that are based on the fair

value of the

enterprise s equity instruments or that may be settled by the issuance of such

equity instruments. In January 2005, the Securities and Exchange

Commission ( SEC ) issued Staff Accounting Bulletin ( SAB ) No. 107,

which provides supplemental implementation guidance for SFAS No. 123R.

SFAS No. 123R eliminates the ability to account for stock-based compensation

transactions using the intrinsic value method under Accounting Principles Board

( APB ) Opinion No. 25, Accounting for Stock

Issued to Employees, and instead generally requires that such

transactions be accounted for using a fair-value-based method. The Company uses the Black-Scholes-Merton

( BSM ) option-pricing model to determine the fair-value of stock-based awards

under SFAS No. 123R, consistent with that used for pro forma disclosures under

SFAS No. 123, Accounting for Stock-Based Compensation.

The Company has elected to use the modified prospective transition method as

permitted by SFAS No. 123R and accordingly prior periods have not been restated

to reflect the impact of SFAS No. 123R.

The modified prospective transition method requires that stock-based

compensation expense be recorded for all new and unvested stock options,

restricted stock, restricted stock units, and employee stock purchase plan

shares that are ultimately expected to vest as the requisite service is rendered

beginning on September 25, 2005, the first day of the Company s fiscal year

2006. Stock-based compensation expense for awards granted prior to September

25, 2005 is based on the grant-date fair-value as determined under the pro

forma provisions of SFAS No. 123. The Company recognized incremental

stock-based compensation expense of $28 million and $86 million during the

third quarter and first nine months of 2006, respectively, as a result of the

adoption of SFAS No. 123R. In accordance with SFAS No. 123R, beginning

in the first quarter of 2006 the Company has presented excess tax benefits from

the exercise of stock-based compensation awards as a financing activity in the

condensed consolidated statement of cash flows.

No stock-based compensation costs have been capitalized as of July 1,

2006. The income tax benefit related to

stock-based compensation expense was $10 million and $36 million for the three

and nine months ended July 1, 2006, respectively. As of July 1, 2006,

$384.5 million of total unrecognized compensation cost related to stock options

and restricted stock units is expected to be recognized over a weighted-average

period of 3.08 years.

SFAS No. 123R

prohibits recognition of a deferred tax asset for an excess tax benefit that

has not been realized. The Company will recognize a benefit from stock-based

compensation in equity if an incremental tax benefit is realized by following

the ordering provisions of the tax law.

In addition, the Company accounts for the indirect effects of

stock-based compensation on the research tax credit, the foreign tax credit,

and the domestic manufacturing deduction through the income statement.

Prior to the adoption of

SFAS No. 123R, the Company measured compensation expense for its employee

stock-based compensation plans using the intrinsic value method prescribed by

APB Opinion No. 25. The Company applied the disclosure provisions of SFAS No.

123 as amended by SFAS No. 148, Accounting for Stock-Based

Compensation Transition and Disclosure, as if the fair-value-based

method had been applied in measuring compensation expense. Under APB Opinion

No. 25, when the exercise price of the Company s employee stock options was

equal to the market price of the underlying stock on the date of the grant, no

compensation expense was recognized.

10

The following